ES468201A1 - Un procedimiento de preparacion de nuevos derivados de la taurina. - Google Patents

Un procedimiento de preparacion de nuevos derivados de la taurina.

Info

Publication number
ES468201A1
ES468201A1 ES468201A ES468201A ES468201A1 ES 468201 A1 ES468201 A1 ES 468201A1 ES 468201 A ES468201 A ES 468201A ES 468201 A ES468201 A ES 468201A ES 468201 A1 ES468201 A1 ES 468201A1
Authority
ES
Spain
Prior art keywords
taurine
neuro
reinforced
derivatives
muscular activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES468201A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cooperation Pharmaceutique Francaise SAS
Original Assignee
Cooperation Pharmaceutique Francaise SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooperation Pharmaceutique Francaise SAS filed Critical Cooperation Pharmaceutique Francaise SAS
Publication of ES468201A1 publication Critical patent/ES468201A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES468201A 1977-03-23 1978-03-22 Un procedimiento de preparacion de nuevos derivados de la taurina. Expired ES468201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7708692A FR2384751A1 (fr) 1977-03-23 1977-03-23 Nouveaux derives de la taurine a activite neuro-musculaire renforcee

Publications (1)

Publication Number Publication Date
ES468201A1 true ES468201A1 (es) 1978-12-01

Family

ID=9188473

Family Applications (1)

Application Number Title Priority Date Filing Date
ES468201A Expired ES468201A1 (es) 1977-03-23 1978-03-22 Un procedimiento de preparacion de nuevos derivados de la taurina.

Country Status (17)

Country Link
US (3) US4199601A (Direct)
JP (1) JPS53149928A (Direct)
AT (1) AT356637B (Direct)
AU (1) AU523705B2 (Direct)
BE (1) BE865163A (Direct)
CA (1) CA1095930A (Direct)
CH (1) CH629479A5 (Direct)
DE (1) DE2810918C2 (Direct)
ES (1) ES468201A1 (Direct)
FR (1) FR2384751A1 (Direct)
GB (1) GB1599962A (Direct)
GR (1) GR62093B (Direct)
IT (1) IT1111455B (Direct)
NL (1) NL7803131A (Direct)
OA (1) OA05914A (Direct)
SE (1) SE443781B (Direct)
ZA (1) ZA781697B (Direct)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457281A1 (fr) * 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US5602150A (en) * 1992-10-02 1997-02-11 Research Foundation For Mental Hygiene, Inc. Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia
US6099869A (en) 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
DK1051393T3 (da) * 1998-01-27 2004-02-02 Merck Sante Sas Hidtil ukendte derivater af aminoalkansulfon-, phosphon- og phosphinsyrer, deres fremstilling og anvendelse som lægemidler
ES2331905T3 (es) * 1999-04-28 2010-01-20 Bellus Health (International) Limited Composiciones y procedimientos para tratar la amiloidosis usando derivados sulfanato.
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6881750B2 (en) * 2003-03-04 2005-04-19 Nutrition Corp. Of America, Ltd. Potassium taurate bicarbonate and ascorbate
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
CA2586111A1 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
AU2005310979A1 (en) * 2004-11-16 2006-06-08 Bellus Health (International) Limited Compounds for the treatment of CNS and amyloid associated diseases
FR2878160B1 (fr) * 2004-11-19 2008-07-25 Jean Pierre Durlach Utilisation du n-acetyl-taurinate de magnesium pour la preparation de medicaments inhibiteurs de l'hypersensiblite photique
US8044100B2 (en) 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
CN101600730B (zh) 2006-10-12 2014-01-29 Bhi有限合资公司 递送3-氨基-1-丙磺酸的方法、化合物、组合物和载体
TW200924748A (en) * 2007-09-07 2009-06-16 Xenoport Inc Masked carboxylate neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
WO2009033079A1 (en) * 2007-09-07 2009-03-12 Xenoport, Inc. Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
WO2009052191A1 (en) * 2007-10-15 2009-04-23 Xenoport, Inc. Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
FR2927809B1 (fr) 2008-02-26 2011-01-14 Tri Inov Nouvelle utilisation de n-acetyl-taurinate de zinc.
RU2453310C1 (ru) * 2010-12-09 2012-06-20 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Средство, обладающее нейропротекторным действием в условиях ишемического поражения мозга и гипоксии, представляющее собой 2-аминоэтансульфонат магния, фармацевтические композиции
FR2973702B1 (fr) 2011-04-08 2013-04-26 Tri Inov N-acetyl-taurinate de zinc pour le traitement du cancer de la prostate
AU2012343935A1 (en) * 2011-11-29 2014-07-03 Basf Se Method for producing and purifying salts of acrylamido-2-methylpropane sulfonic acid
KR102055492B1 (ko) 2015-06-17 2019-12-12 마가렛 진 프로펫 여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제
CN112472717B (zh) * 2015-12-25 2022-08-09 北京乳凝创智生物技术研发中心(有限合伙) 一种医疗器械外用制剂
BE1025644B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement d'une maladie ou d'un trouble du systeme nerveux central chez un sujet en stimulant et/ou en restaurant la plasticite neuronale
BE1025645B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement de la neurotoxicite due a l'hyperexcitabilite des recepteurs glutamatergiques ionotropes
EP3738588A1 (en) 2019-05-13 2020-11-18 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
CA3137407A1 (fr) 2019-05-16 2020-11-19 Synapharm Industrial Synthesis Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder
PT3738596T (pt) 2019-05-16 2022-06-02 Synapharm Ind Synthesis Composto e composição para utilização no tratamento da síndrome pré-menstrual e/ou distúrbio disfórico pré-menstrual
BE1026955B1 (fr) * 2019-06-11 2020-08-04 Synapharm Ind Synthesis Procédé de fabrication de N-acétyl-taurinate de magnésium
RU2730835C1 (ru) * 2019-10-23 2020-08-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(3-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью в сочетании с церебропротективным действием
RU2731106C1 (ru) * 2019-10-23 2020-08-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(4-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью
WO2021245697A1 (en) 2020-06-01 2021-12-09 Celagenex Research (India) Pvt. Ltd. Novel synergistic medicinal compositions for treating dysfunctional d-serine signaling
CN119504517B (zh) * 2025-01-22 2025-04-18 浙江天启生化股份有限公司 一种乙酰牛磺酸镁的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232968A (en) * 1959-12-01 1966-02-01 Gen Aniline & Film Corp Process for preparing n-acyl taurates using hypophosphorous acid as catalyst
US3344174A (en) * 1962-08-21 1967-09-26 Monsanto Co Vicinal acylamido sulfonate compounds
DE1256650B (de) * 1965-08-07 1967-12-21 Dr Dieter Arlt Verfahren zur Herstellung von N-acylierten 2-Amino-alkan-sulfonsaeuren-(1) bzw. von 2-Amino-alkan-sulfonsaeuren-(1)
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
US3960918A (en) * 1973-06-26 1976-06-01 The Lubrizol Corporation Preparation of esters of amidoalkanesulfonic acids

Also Published As

Publication number Publication date
IT7867631A0 (it) 1978-03-22
NL7803131A (nl) 1978-09-26
AT356637B (de) 1980-05-12
DE2810918C2 (de) 1985-06-20
AU3463478A (en) 1979-10-04
JPS53149928A (en) 1978-12-27
JPS6256867B2 (Direct) 1987-11-27
FR2384751A1 (fr) 1978-10-20
CH629479A5 (fr) 1982-04-30
GB1599962A (en) 1981-10-07
OA05914A (fr) 1981-06-30
US4271189A (en) 1981-06-02
GR62093B (en) 1979-02-22
SE443781B (sv) 1986-03-10
ZA781697B (en) 1979-03-28
SE7803032L (sv) 1978-09-24
US4267194A (en) 1981-05-12
AU523705B2 (en) 1982-08-12
BE865163A (fr) 1978-09-22
CA1095930A (en) 1981-02-17
FR2384751B1 (Direct) 1979-07-20
DE2810918A1 (de) 1978-09-28
US4199601A (en) 1980-04-22
ATA202878A (de) 1979-10-15
IT1111455B (it) 1986-01-13

Similar Documents

Publication Publication Date Title
ES468201A1 (es) Un procedimiento de preparacion de nuevos derivados de la taurina.
IE883845L (en) Adenosine derivative
GR852904B (Direct)
ES473754A1 (es) Procedimiento de preparacion de composiciones farmaceuticas a base de nuevas w-tiopropinamidas, y de sus sales con una base mineral y organica
GR3002588T3 (en) Process for preparing retinoyl chlorides
JPS5422350A (en) Purification of aromatic polyamines
ES467300A1 (es) Un metodo de preparacion de un derivado de 9-hidroxietoxime-tilguanina.
MY103731A (en) New 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes
JPS5271456A (en) Synthesis of 1alpha-hydroxysteroid derivatives
ES8403110A1 (es) Un procedimiento para la preparacion de pirbuterol.
TNSN88070A1 (fr) Procede de preparation de l'acide (pyridyl-3)-3-1h, 3h-pyrrolo (1,2-c) thiazolecarboxylique-7dextrogyre
FR2380277A1 (fr) L'antibiotique desacetyl, dihydro 890 a9
JPS5427542A (en) Preparation of isoprene cyclic trimer
GB1448295A (en) Thiosemicarbazones
GB2001643A (en) Preparing aqueous solutions of alkali metal salts of Armstrong acid
GB1491962A (en) Process for the production of cephem compounds
GB1464160A (en) Rapid hardening cement
GB1497723A (en) Octahydrobenzo-(c)(1,6)-naphthyridine derivative
JPS5412350A (en) Preparation of trans-chrysanthemum-monocarboxylic acid chloride
ES442473A1 (es) Procedimiento para la preparacion de 3, 7-dimetil-3-hidroxi-6-octenonitrilo.
ES470496A1 (es) Proceso para la preparacion de tris (hidroximetil)-aminome- tan-lactato-dihidroxialuminato
JPS5398911A (en) Preparation of dichlorobutenes
GB939251A (en) 4-chloro-6-fluorobenzene-1,3-disulphonamide and a method of preparing it
FR2380254A1 (fr) Procede perfectionne pour la preparation des isocyanates d'alkyle
JPS53147022A (en) Stabilization of unsaturated tertiary amine or its quaternary ammonium salt

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19891107